Detalhe da pesquisa
1.
Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer.
Ann Surg
; 269(1): 83-87, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28742685
2.
Prospective multicenter registration study of colorectal cancer: significant variations in radicality and oncosurgical quality-Swiss Group for Clinical Cancer Research Protocol SAKK 40/00.
Int J Colorectal Dis
; 32(1): 57-74, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714521
3.
Is surgical quality more important than radicality? Long-term outcomes of stage I-III colon cancer (SAKK 40/00).
Surg Oncol
; 55: 102092, 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843695
4.
The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brief tool for clinical decision-making in older cancer patients.
BMC Med Inform Decis Mak
; 13: 93, 2013 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23971904
5.
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.
Haematologica
; 97(7): 1085-91, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315486
6.
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer Research (SAKK 75/02).
Gastrointest Endosc
; 71(7): 1114-21, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20304399
7.
Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).
Onkologie
; 32(12): 724-30, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20016233
8.
What can we learn from the ZOOM trial?
Lancet Oncol
; 14(10): e388, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23993382
9.
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores.
Ther Adv Med Oncol
; 11: 1758835918818351, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30636977
10.
Clinical and pharmacogenetic determinants of 5-fluorouracyl/leucovorin/irinotecan toxicity: Results of the PETACC-3 trial.
Eur J Cancer
; 99: 66-77, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909091
11.
Implementation science in Switzerland: It's time to seize the opportunity.
Swiss Med Wkly
; 152: 40021, 2022 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535022
12.
Phase I trial of the androgen receptor modulator CR1447 in breast cancer patients.
Endocr Connect
; 6(7): 549-556, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28814476
13.
External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26.
Radiat Oncol
; 12(1): 12, 2017 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28086942
14.
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Cancer Treat Rev
; 48: 61-8, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27362548
15.
Phase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer.
J Clin Oncol
; 20(7): 1759-66, 2002 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11919232
16.
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07).
Leuk Lymphoma
; 55(1): 87-91, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23547838
17.
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: a multicenter phase II trial (SAKK 19/05).
Lung Cancer
; 78(3): 239-44, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23009726
18.
Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07).
Clin Cancer Res
; 18(21): 6049-57, 2012 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22977195
19.
Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06).
J Clin Oncol
; 29(6): 626-31, 2011 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21205757
20.
Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).
Leuk Lymphoma
; 51(4): 613-9, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20218808